Medication info
Stoga Tablet 10 mg (Lafutidine)

Stoga Tablet 10 mg (Lafutidine)

Prescription medicationTabletOral
Ingredient · strength
Lafutidine›10mg / 1 tablet
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200607849 · Approved 2006.09.29 · Insurance code 641902670

Summary

Main use
Treatment of gastrointestinal disorders (ulcers, gastritis, etc.), use in combination for eradication therapy, and pre-anesthetic medication
Who takes it
Adults
Adult dose
1. Short-term treatment of gastric ulcers The usual dose is 10mg of lafutidine orally twice daily, in the morning and at bedtime. Clinical trials of up to 8 weeks showed that most ulcers healed within 8 weeks, although healing time may vary in some patients. 2. Short-term treatment of duodenal ulcers The usual dose is 10mg of lafutidine orally twice daily, in the morning and at bedtime. Clinical trials of up to 6 weeks showed that most ulcers healed within 6 weeks, although healing time may vary in some patients. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis The usual dose is 10mg of lafutidine orally once daily at bedtime. Clinical trials of up to 2 weeks showed that most lesions healed within 2 weeks, although healing time may vary in some patients. 4. Combination therapy with antibiotics in patients with peptic ulcers infected with Helicobacter pylori Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication for anesthesia The usual dose is 10mg of lafutidine orally twice (at bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis Administer 10mg of lafutidine orally twice daily.

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (ulcers, gastritis, etc.), use in combination for eradication therapy, and pre-anesthetic medication

  • Gastric ulcers
  • duodenal ulcers
  • gastric mucosal lesions due to acute gastritis and chronic gastritis
  • peptic ulcers
  • gastroesophageal reflux disease
View approved original text

This medication is effective in treating gastric ulcers and duodenal ulcers. It also helps improve gastric mucosal damage caused by acute and chronic gastritis. For patients with peptic ulcers infected by Helicobacter pylori, it is used in combination with antibiotics. The medication is also used as a pre-operative medication and is effective in treating gastroesophageal reflux disease. It is widely used to treat various gastrointestinal disorders.

How to take

Adult dose

1. Short-term treatment of gastric ulcers The usual dose is 10mg of lafutidine orally twice daily, in the morning and at bedtime. Clinical trials of up to 8 weeks showed that most ulcers healed within 8 weeks, although healing time may vary in some patients. 2. Short-term treatment of duodenal ulcers The usual dose is 10mg of lafutidine orally twice daily, in the morning and at bedtime. Clinical trials of up to 6 weeks showed that most ulcers healed within 6 weeks, although healing time may vary in some patients. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis The usual dose is 10mg of lafutidine orally once daily at bedtime. Clinical trials of up to 2 weeks showed that most lesions healed within 2 weeks, although healing time may vary in some patients. 4. Combination therapy with antibiotics in patients with peptic ulcers infected with Helicobacter pylori Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication for anesthesia The usual dose is 10mg of lafutidine orally twice (at bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis Administer 10mg of lafutidine orally twice daily.

Precautions

This medication should not be taken by individuals allergic to its ingredients. Additionally, since it contains lactose, individuals with genetic disorders that inhibit lactose digestion should not take this medication. Individuals who have previously shown allergic reactions to medications, those with liver or kidney function issues, dialysis patients, and the elderly should exercise caution when using this medication. While taking this medication, there may be side effects such as severe allergic reactions, liver dysfunction, or a decrease in blood cell counts, so symptoms should be closely monitored. If symptoms such as pallor or difficulty breathing occur, the medication should be discontinued immediately, and a doctor should be consulted. It is also important to periodically check liver function tests, as levels may rise or jaundice may appear. If blood tests show a decrease in white blood cells or platelets, medical advice should be sought immediately if any abnormal symptoms arise. Rarely, serious side effects such as skin rashes, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rashes with fever, blisters, skin peeling, pain in oral/eye mucosa, shortness of breath or breathing difficulties, asthma attacks, cough with fever, jaundice, extreme fatigue, sudden severe headaches, thunderclap headaches, seizures, confusion, visual disturbances, paralysis, or changes in urination may occur, so any unusual symptoms should be reported promptly to healthcare professionals. Gastrointestinal side effects including constipation, diarrhea, nausea, vomiting, abdominal bloating, and loss of appetite have been reported. Central nervous system side effects such as headaches, insomnia, and drowsiness may also occur. Elderly patients or those with reduced kidney function may have increased blood concentration of the medication, so caution should be taken by adjusting the dose and monitoring closely. Pregnant women or those who may become pregnant should carefully consider the benefits and risks before taking this medication, and breastfeeding women should avoid its use. The safety of this medication in children has not been sufficiently confirmed, so its use should be avoided. This medication should be kept out of reach of children and stored in its original container safely. Finally, this medication may mask the symptoms or delay the diagnosis of malignant tumors, so if stomach cancer or other malignant tumors are suspected, testing must be conducted, and if confirmed, the medication should be discontinued.

Side effects

  • Shock
  • symptoms of anaphylaxis
  • facial pallor
  • hypotension
  • generalized rash
  • dyspnea
  • liver dysfunction
  • jaundice
  • agranulocytosis
  • pharyngalgia
Show 80 more
  • general malaise
  • fever
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • seizures
  • interstitial nephritis
  • Stevens-Johnson syndrome
  • Liell syndrome
  • rhabdomyolysis
  • heart block
  • inadequate contraction
  • constipation
  • diarrhea
  • hard stools
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • headache
  • insomnia
  • drowsiness
  • reversible confusional state
  • hallucinations
  • consciousness disturbances
  • dizziness
  • chills
  • sensation of heat
  • facial flushing
  • leukocytosis
  • eosinophilia
  • leukopenia
  • erythrocytopenia
  • decreased hematocrit
  • elevated ALT
  • elevated AST
  • elevated Al-P
  • elevated γ-GTP
  • elevated T-Bil
  • elevated LDH
  • elevated TTT
  • abnormal urinary protein
  • elevated BUN
  • elevated serum uric acid
  • elevated Cl
  • delayed menses
  • elevated Na
  • decreased K
  • gynecomastia
  • edema
  • malaise
  • glossitis
  • headache
  • urticaria
  • skin rash
  • abdominal pain
  • dyspepsia
  • enteritis
  • gastric ulcer
  • erosive gastritis
  • duodenitis
  • bloating
  • nasopharyngitis
  • upper respiratory infection
  • bronchopneumonia
  • tinea
  • cough
  • oropharyngeal pain
  • oropharyngeal discomfort
  • wet cough
  • fatigue
  • chest pain
  • limb pain
  • arthralgia
  • cervical pain
  • pruritus
  • acne
  • contusion
  • insomnia
  • non-alcoholic fatty liver disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius to preserve the medication's efficacy for a longer period.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.